Beam Therapeutics Inc (BEAM) — Cash Flow Quality Index

Latest as of December 2025: -0.34x

Beam Therapeutics Inc (BEAM) has a Cash Flow Quality Index of -0.34x as of December 2025. Operating cash flow of $-83.29 Million is below net income of $244.30 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Beam Therapeutics Inc strategic investment ratio to see how much of total assets are deployed in long-term investments.

Cash Flow Quality Index

-0.34x

Operating CF / Net Income

Operating Cash Flow

$-83.29 Million

USD

Net Income

$244.30 Million

USD

Data as of

Dec 2025

Most recent filing

Annual Cash Flow Quality Index for Beam Therapeutics Inc (None–None)

Year-by-year earnings quality comparison for Beam Therapeutics Inc. For live market cap and the full company financial profile, see Beam Therapeutics Inc market capitalisation.

Year	Quality Index	Operating CF (USD)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.